参考文献/References:
[1] 中华医学会神经病学分会痴呆与认知障碍学组写作组.血管性认知障碍诊治指南[J].中华神经科杂志,2011,44(2):142-147.
[2] 张雪玲,王黎明,陈念东,等.血管性认知功能障碍与C-反应蛋白、同型半胱氨酸、维生素B12及叶酸的相关性研究[J].卒中与神经疾病,2018,25(1):71-74.
[3] Alzhemier.s disease international.world alzheimer report 2018:the state of art of dementia research:new frontiers[M].London:alzhemier[Z],2018:34.
[4] Liu Q,Zhu Z,Teipel SJ,et al.White matter damage in the cholinergic system contributes to cognitive impairment in subcortical vascular cognitive impairment, no dementia[J].Front Aging Neurosci,2017,9:47.
[5] 中国痴呆与认知障碍写作组,中国医师协会神经内科医师分会认知障碍疾病专业委员会.2018中国痴呆与认知障碍诊治指南(二):阿尔茨海默病诊治指南[J].中华医学杂志,2018,98(13):971-977.
[6] Katyal A,Kumaran D,Udayabanu M.Behavioural dysfunction and delayed neuronal death associated with cholinergic hypofunction during global cerebral ischemia and the effect of rivastigmine, galantamine and choline[J].International Journal of Developmental Neuroscience,2012,30(8):670.
[7] Farooq MU,Min JY,Goshgarian CA.Pharmacotherapy for vascular cognitive impairment[J].CNS Drugs,2017,31(9):759-776.
[8] Narasimhalu K,Effendy S,Sim CH,et al.A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease[J].Acta Neurol Scand,2010,121(4):217-224.
[9] Ballard C,Sauter M,Scheltens P,et al.Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia:the VantagE study[J].Curr Med Res Opin,2008,24(9):2561-2574.
[10] Ye Q,Bai F.Contribution of diffusion,perfusion and functional MRI to the disconnection hypothesis in subcortical vascular cognitive impairment[J].Stroke Vasc Neurol,2018,3(3):131-139.
[11] Mok V,Wong A,Ho S,et al.Rivastigmine in Chinese patients with subcortical vascular dementia[J].Neuropsychiatr Dis Treat,2007,3(6):943-948.
[12] Chen X, Zhang Z, Qian C, et al. Clinical efficacy and safety of rivastigmine in treatment of vascular dementia:a multi-center, open-label, randomized, controlled trial[J]. 2005,38(8):483-487.
[13] Kavirajan H,Schneider LS.Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia:a meta-analysis of randomised controlled trials[J].Lancet Neurol,2007,6(9):782-792.
[14] Moretti R,Torre P,Antonello RM,et al.Different responses to rivastigmine in subcortical vascular dementia and multi-infarct dementia[J].Am J Alzheimers Dis Other Demen,2008,23(2):167-176.
[15] Moretti R,Torre P,Antonello RM,et al.Rivastigmine in subcortical vascular dementia:a randomized,controlled,open 12-month study in 208 patients[J].Am J Alzheimers Dis Other Demen,2003,18(5):265-272.
[16] Moretti R, Torre P, Antonello R M, et al. Rivastigmine in subcortical vascular dementia:an open 22-month study[J]. J Neurol Sci,2002,203-204:141-146.
[17] Moretti R,Torre P,Antonello RM,et al.Rivastigmine superior to aspirin plus nimodipine in subcortical vascular dementia:an open, 16-month, comparative study[J].Int J Clin Pract,2004,58(4):346-353.